Investment Considerations for Dermatology and Aesthetics Practices with Clint Bundy and Stewart Carlin

Dermatology and aesthetics practices took off after the Great Recession, thrived during Covid, and now show no signs of slowing down. What makes dermatology and aesthetics such desirable investments?

In this episode of The Corner Series, McGuireWoods’ Geoff Cockrell chats with Clint Bundy and Stewart Carlin, managing directors of the Bundy Group, a boutique investment bank specializing in the healthcare industry, to discuss specific considerations for investing in dermatology and aesthetics practices.

Listen as Clint and Stewart explain why those practices are high-value investment targets, including the increasing influence of healthcare technology, the difference between being an investment cornerstone versus an add-on acquisition, and how aggressive investors will keep the market for dermatology and aesthetics providers robust.

Connect and Learn More

☑️ Clint Bundy | LinkedIn 

☑️ Stewart Carlin | LinkedIn 

☑️ Bundy Group | LinkedIn

☑️ Geoff Cockrell | LinkedIn

☑️ McGuireWoods | LinkedIn | Facebook | Instagram | Twitter/X

☑️ Subscribe Apple Podcasts | Spotify | Amazon Music

This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.